Nedd4, a ubiquitin-protein ligase, was originally identi®ed as being down-regulated during development of the mouse brain (Nedd denotes neural precursor cell expressed developmentally down-regulated) (Kumar, S., Tomooka, Y., Noda, M., 1992. Identi®cation of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem. Biophys. Res. Commun. 185, 1155±1161). Subtractive hybridization was used in an attempt to identify genes that are preferentially expressed early in skeletogenesis. Using this technique Nedd4 was identi®ed multiple times. Northern blot analysis con®rmed that Nedd4 is down-regulated in the forelimb and hind limb. In situ hybridization was carried out to identify regions of the limb bud expressing Nedd4. Nedd4 is expressed weakly in condensing mesenchyme, and abundantly in proliferating and prehypertrophic chondrocytes, but is undetectable in hypertrophic chondrocytes. Primary cultures, which closely mimic in vivo chondrogenesis, were also used to demonstrate the stage-speci®c expression of Nedd4 during early skeletal development. q
Results
Nedd4 was ®rst identi®ed as a transcript that is abundantly expressed in the embryonic mouse brain, but declines as development of the central nervous system progresses (Kumar et al., 1992) . Subsequently Nedd4 was found to be expressed in various embryonic and adult tissues and to encode a protein containing a calcium/lipid binding domain, protein-protein interaction domains (Staub et al., 1996 (Staub et al., , 1997 Kumar et al., 1997) , and a ubiquitin-protein ligase domain (Bork and Sudol, 1994; Kumar et al., 1997) . To date, Nedd4 has been shown to bind to only a handful of proteins (Staub et al., 1996; Gavva et al., 1997; Morrione et al., 1999) , but is emerging as a protein having diverse cellular functions (for review see Harvey and Kumar, 1999) . Given these diverse functions and the widespread expression of Nedd4 there are likely several additional proteins whose activity and/or function is regulated by Nedd4.
In an effort to identify genes that are expressed more abundantly during the early stages of skeletogenesis, subtractive hybridization between E11.5 and E15 mouse forelimb mRNA was carried out. Of the transcripts isolated, Nedd4 was identi®ed at a frequency of~2%. Northern blot analysis con®rmed the differential expression of Nedd4 in the forelimb and in the hind limb (Fig. 1A) . Whole-mount in situ hybridization reveals that in E13 mouse embryos, Nedd4 is mostly restricted to the digital regions of both the fore-and hind limb, indicating it may be expressed in cartilaginous elements (Fig. 1B±E) . Although the Nedd4-transcript has been detected in many developing organs, various adult tissues, and in cultured cells, it's expression in the developing limb has not been characterized. Moreover, there are no reports to date of expression of Nedd4 in the developing skeleton. Primary limb bud cultures were initially used to examine if chondrocytes express Nedd4. When dissociated limb mesenchymal cells are plated at high density (1±2 £ 10 7 cells/ml), they will closely mimic the sequence of events that occur during in vivo chondrogenesis; chondroprogenitors undergo condensation, then condensed cells differentiate to form many cartilage nodules (Ahrens et al., 1977) . In situ hybridization of these cultures reveals distinct expression of Nedd4 within cartilage nodules, con®rming its expression in chondrocytes (Fig.  1F±I ).
Limb bud sections were used to identify possible changes in Nedd4 expression throughout skeletal development. Cartilage formation begins with the condensation of mesenchyme followed by differentiation of this mesenchyme into chondrocytes. As development proceeds, chondrocytes progress from proliferating chondrocytes through an intermediate, prehypertrophic cell type then undergo hypertrophy. To identify possible changes in Nedd4 expression throughout skeletal development, in situ hybridization on mouse limb bud sections of E14.5 and E15.5 embryos was carried out. Various stages of cartilage development are represented on these sections, from condensed mesenchyme to hypertrophic chondrocytes, making it possible to look at many stages of skeletogenesis simultaneously. Nedd4 is expressed weakly in condensing mesenchyme, and more abundantly in proliferating chondrocytes, and prehypertrophic chondrocytes, but its expression is not detectable beyond background levels in hypertrophic chondrocytes (Fig. 2A±H) . The background staining seen in the hypertrophic region may result from endogenous alkaline phosphatase activity which is present in this region. A similar pattern of expression was seen in the hind limb (Fig. 2I±L ). This decrease in Nedd4 expression seen in hypertrophic chondrocytes may explain the down-regulation of Nedd4 that occurs during limb development. Nedd4 is also expressed abundantly in the joint regions and the perichondrium, which is the sheath of undifferentiated cells around the cartilage.
When primary cultures are maintained for a prolonged period of time, and treated with ascorbate and b-glycerophosphate, chondrocytes will undergo hypertrophy (Mello and Tuan, 1999) . These hypertrophic cells are clearly identi®able based on their large size, expression of type X collagen, and increased alkaline phosphatase activity. Using this in vitro culture system, we demonstrated a lack of Nedd4 expression in hypertrophic chondrocytes, but observed that less mature cells surrounding nodules of hypertrophic cells, express Nedd4 abundantly (Fig. 2M±  P) . Taken together, these results strongly suggest that Nedd4 expression increases during chondrocyte differentia- tion, whereas the transition of prehypertrophic chondrocytes to hypertrophic chondrocytes is accompanied by a decrease in Nedd4.
Materials and methods

Subtractive hybridization
Amersham Pharmacia Biotech's QuickPrep Micro mRNA Puri®cation Kit was used to isolate polyadenylated RNA from the forelimbs of E11.5 and E15 mouse (C57Bl6F1/J) embryos. Clontech's PCR-Select cDNA Subtraction Kit was used to carry out subtractive hybridization with mRNA from E11.5 embryos used as`tester' and mRNA from E15 embryos used as`driver'. PCR products of the subtraction protocol were cloned into pGEM-T-Easy (Promega) and sequenced using Amersham Pharmacia Biotech's T7 Sequencing Kit. Clone identities were determined through BLAST sequence homology searches of GenBank (National Center for Biotechnology Information).
Preparation of cultures from limb mesenchyme
Cultures were prepared from mouse fore limb buds of E11.5 embryos (taken from C57Bl6F1/J females), as Fig. 2 . Stage-speci®c expression of Nedd4 during chondrogenesis. Nedd4 is expressed at various stages of chondrogenesis, as seen in sections of E14.5 forelimb buds (A-antisense; B-sense). At E14.5, condensed mesenchyme is still present surrounding some elements such as those representing the future distal phalanges. Although cartilage differentiation has commenced in the cores of these elements, there is still considerable condensing mesenchyme around the newly formed cartilage. Nedd4 appears to be expressed in condensed, undifferentiated mesenchyme but at much lower levels than in chondrocytes (C, see arrows). Also note the intense expression at the joint regions (D, see arrows), and in the perichondrium (E, see arrow). The developing long bones such as the radius and ulna display the various stages of chondrogenesis clearly. Nedd4is expressed in the proliferating chondrocytes and in pre-hypertrophic chondrocytes, but is undetectable in hypertrophic chondrocytes (E-antisense, F-sense). This decrease in Nedd4 as chondrocytes become hypertrophic is also very pronounced at E15.5 as seen in the developing ulna (G-antisense, H-sense). A similar pattern of Nedd4expression is seen in the developing bones of the hind limb at E15.5. The proliferating chondrocytes such as those of the developing tarsal bones express Nedd4 abundantly (I-antisense, J-sense), as do the proliferating and prehypertrophic chondrocytes of the developing tibia where the transcript is not detectable beyond background levels in the hypertrophic chondrocytes (Kantisense, L-sense). There is a decrease in Nedd4 expression in cultured hypertrophic chondrocytes in comparison to less mature chondrocytes surrounding the various nodules of hypertrophic cells (M,O-antisense, N,P-sense). cm, condensing mesenchyme; pc, proliferating chondrocytes; phc, prehypertrophic chondrocytes; hc, hypertrophic chondrocytes. Scale bars, 0.6 mm (A,B); 0.1 mm(C); 0.4 mm (D±F); 0.2 mm (G,H); 0.2 mm (I±L); 0.7 mm (M,N); and 1.3 mm (O,P).
previously described (Weston et al., 2000) . To study proliferating chondrocytes, cultures were ®xed 4 days after they were initiated. To allow cultured chondrocytes to reach hypertrophy, 10 mM b-glycerophosphate and 50 mg/ml ascorbate was added with daily media changes. These cultures were ®xed after 24 days, embedded, and sectioned at 8 mm.
Nedd 4 expression analysis
A 288 bp fragment in pGEM-T-Easy, that was isolated from the subtractive hybridization and corresponds to Nedd4, was used to generate a P 32 -labeled probe for northern blot analysis, and dig-labeled sense and antisense probes for in situ hybridization. This fragment is from bp position 3487±3726 of the nedd4 gene, and encodes part of the ubiquitin-protein ligase domain (hect domain). Northern blot analysis was carried out as described previously (Weston et al., 2000) . Whole-mount in situ hybridization of embryos was performed as described by (Conlon and Rossant, 1992) . Modi®cations of the whole-mount protocol that were used for in situ hybridization of micromass cultures were described previously (Cash et al., 1997) . Section in situ hybridization of 8 mm sections of cultures and 6 mm sections of limb buds was carried out using the protocol of Breitschopf et al. (1992) , as outlined in the Nonradioactive In Situ Hybridization Application Manual (Boehrhinger Mannheim).
